Azitra (NYSEAMERICAN:AZTR) Issues Quarterly Earnings Results

Azitra (NYSEAMERICAN:AZTR) issued its quarterly earnings results on Thursday. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.04), FiscalAI reports.

Azitra Trading Up 14.2%

Shares of Azitra stock traded up $0.08 during midday trading on Thursday, hitting $0.67. The company had a trading volume of 216,001 shares, compared to its average volume of 1,539,252. The business’s 50 day simple moving average is $1.72 and its two-hundred day simple moving average is $1.86. Azitra has a 1-year low of $0.52 and a 1-year high of $4.30.

Azitra Company Profile

Azitra, Inc. is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin. Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment. Its development programs have focused on conditions including inflammatory skin disorders, rare genetic diseases and treatment-related dermatologic complications.